1. Home
  2. LNTH vs BNL Comparison

LNTH vs BNL Comparison

Compare LNTH & BNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LNTH
  • BNL
  • Stock Information
  • Founded
  • LNTH 1956
  • BNL 2007
  • Country
  • LNTH United States
  • BNL United States
  • Employees
  • LNTH N/A
  • BNL N/A
  • Industry
  • LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • BNL Real Estate Investment Trusts
  • Sector
  • LNTH Health Care
  • BNL Real Estate
  • Exchange
  • LNTH Nasdaq
  • BNL Nasdaq
  • Market Cap
  • LNTH 3.6B
  • BNL 3.5B
  • IPO Year
  • LNTH 2015
  • BNL 2020
  • Fundamental
  • Price
  • LNTH $53.83
  • BNL $18.68
  • Analyst Decision
  • LNTH Strong Buy
  • BNL Buy
  • Analyst Count
  • LNTH 6
  • BNL 7
  • Target Price
  • LNTH $85.50
  • BNL $19.71
  • AVG Volume (30 Days)
  • LNTH 1.5M
  • BNL 1.6M
  • Earning Date
  • LNTH 11-05-2025
  • BNL 10-29-2025
  • Dividend Yield
  • LNTH N/A
  • BNL 6.21%
  • EPS Growth
  • LNTH N/A
  • BNL N/A
  • EPS
  • LNTH 3.77
  • BNL 0.52
  • Revenue
  • LNTH $1,520,653,000.00
  • BNL $442,203,000.00
  • Revenue This Year
  • LNTH N/A
  • BNL $4.91
  • Revenue Next Year
  • LNTH $3.24
  • BNL $5.98
  • P/E Ratio
  • LNTH $14.27
  • BNL $36.00
  • Revenue Growth
  • LNTH 5.75
  • BNL 3.85
  • 52 Week Low
  • LNTH $47.25
  • BNL $13.96
  • 52 Week High
  • LNTH $118.21
  • BNL $18.86
  • Technical
  • Relative Strength Index (RSI)
  • LNTH 50.57
  • BNL 62.48
  • Support Level
  • LNTH $49.75
  • BNL $17.53
  • Resistance Level
  • LNTH $54.43
  • BNL $18.41
  • Average True Range (ATR)
  • LNTH 1.51
  • BNL 0.29
  • MACD
  • LNTH 0.61
  • BNL -0.04
  • Stochastic Oscillator
  • LNTH 87.11
  • BNL 95.02

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.

About BNL Broadstone Net Lease Inc.

Broadstone Net Lease Inc is an internally managed real estate investment trust that invests in, owns, and manages single-tenant commercial real estate properties that are net leased on a long-term basis to a diversified group of tenants. The company has selectively invested in net leased assets in the industrial, healthcare, restaurant, retail, and office property types. The company focuses on investing in real estate that is operated by creditworthy single tenants in industries characterized by positive business drivers and trends. The company targets properties that are an integral part of the tenants' businesses and are therefore opportunities to secure long-term net leases.

Share on Social Networks: